Experts Sound the Alarm: RFK Jr.’s Conspiracy Theories Threaten Lives, Warn Analysts from Lutnick’s Prestigious Firm
In a dramatic twist within the U.S. administration, President Donald Trump addressed the press before signing an Executive Order at the Oval Office, flanked by Health and Human Services Secretary Robert F. Kennedy Jr. and Commerce Secretary nominee Howard Lutnick. This follows the controversial appointment of Kennedy, a known vaccine skeptic, which has sparked significant debate about the direction of U.S. health policies.
Robert F. Kennedy Jr.’s appointment has not been without controversy. Analysts from Cantor Fitzgerald, a firm previously led by the new Commerce Secretary, Howard Lutnick, criticized Kennedy’s credentials, calling his leadership at the Health and Human Services (HHS) “inappropriate” given its mission to safeguard American health. This backlash was intensified by the resignation of Peter Marks, who was head of the FDA’s biologics division. Marks exited in protest against Kennedy’s stances, which are perceived to threaten public trust in vaccines.
Kennedy’s opposition to widely accepted vaccine science, specifically his stance on the measles, mumps and rubella vaccine, and his promotion of unverified treatments during recent measles outbreaks, has alarmed public health experts. His controversial views reportedly resonate with a discredited study suggesting a link between vaccines and autism, which the Centers for Disease Control and Prevention is currently reviewing, led by a questionable researcher.
Cantor Fitzgerald analysts Josh Schimmer and Eric Schmidt expressed concern in a memo to clients. “We call on the administration to re-evaluate RFK Jr’s role at HHS. Pushing out one of the most trusted leaders of the FDA to promote an anti-science agenda is a step too far,” they wrote, emphasizing that HHS leadership should not rest with someone deemed to have an “anti-vax, conspiracy theorist” background. The analysts cautioned against the implications of Kennedy’s leadership, stressing he lacks the necessary training to effectively manage the agency’s critical health functions.
The pharmaceutical market responded negatively to this turmoil. Shares in vaccine manufacturers like Moderna and Novavax fell significantly, with both experiencing drops exceeding 8%. The broader biotech sector also saw declines, as measured by the SPDR S&P Biotech ETF, which slid nearly 4% following Marks’ resignation. However, financial analysts stress that the gravity of this issue transcends stock market fluctuations, highlighting the larger implications of policy shifts on public health.
Despite immediate impacts on vaccine-related stocks, Cantor analysts underlined that the debate was centered around public welfare. “We already had a needless measles death. It’s time to end the narrative of ‘just take Vitamin A’ and ‘give individuals the freedom to choose’ while propagating the myth that vaccines cause autism,” they urged.
While HHS has remained silent on these internal controversies, the situation continues to unfold under the watchful eyes of health experts and public investors. Kennedy’s role and the federal government’s health strategy are now critical focal points for both public health policy and market observers.
Lutnick, who recently transitioned from his longstanding role at Cantor Fitzgerald to assume duties as Commerce Secretary, is yet to comment on the situation. The implications of these developments on U.S. health policy and public trust remain to be seen as the administration deals with mounting skepticism from both industry and public health advocates.
Original Source: https://www.cnbc.com/2025/04/01/rfk-jr-is-a-conspiracy-theorist-endangering-lives-say-analysts-at-howard-lutnicks-former-firm.html
Category :
Tags:
Publish Date: 2025-04-01 18:24:00
